Table 7.
Demographic and operative parameters from the case-control study for EPO/ABD (w women; m men; PSFI posterior spinal fusion with instrumentation; PLIF posterolateral interbody fusion)
| EPO | ABD | |
|---|---|---|
| Sex | 8 w/2 m | 7 w/3 m |
| *Age (years) | 51.5 | 39.3 |
| (39–66) | (26–51) | |
| Type of surgery | PSFI 11 | PSFI 12 |
| PLIF 8 | PLIF 8 | |
| Hb baseline (g/dl) | 12.9 | 13.05 |
| **EPO units administered | 3.1 units/patient | 0 |
| **ABD units | 0 | 2.8 units/patient |
| Hb day of surgery (g/dl) | 14.2 | 10.7 |
| **Surgery duration (min) | 3 h 12 min | 3 h 29 min |
| ***Total bleeding (ml) | 1,176±360.1 | 814.2±307.5 |
| Allogenic transfusion | 0 | 0 |
| Hb at discharge (g/dl) | 11.1 | 11.1 |
| Days hospitalisation | 9.2 | 9 |
*Age is expressed as mean and range
**Values for EPO administration, ABD units and surgery duration are expressed as means
***Data for total bleeding are expressed as the mean±standard error